UBS Maintains Buy on Fermi, Lowers Price Target to $8

UBS analyst John Hodulik has maintained a Buy rating on Fermi (NASDAQ: FRMI) but has reduced the price target from $30 to $8. This adjustment reflects a significant change in the expected valuation of the company.